Should patients with high-risk coronary artery disease be treated with CABG or receive drug-eluting stents? The SYNTAX trial aimed to define the optimal revascularization strategy for patients with ...

September 1, 2008 (Munich, Germany) — One-year follow-up from the much anticipated Synergy Between PCI With Taxus and Cardiac Surgery (SYNTAX) trial indicates that drug-eluting stents (DES) are ...